Drug class
Class IC antiarrhythmic; voltage-gated sodium-channel blocker
Mechanism of action
Blocks fast voltage-gated sodium channels in cardiac myocytes, slowing phase-0 depolarisation and conduction velocity. It can suppress abnormal atrial and ventricular impulse propagation but may be proarrhythmic in structural heart disease.
General use cases
- Treatment of selected supraventricular and ventricular tachyarrhythmias in countries where ethacizine is authorised, under specialist ECG monitoring; use is highly jurisdiction-specific and not a general first-line antiarrhythmic indication
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
